Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified. more
| Time Frame | BIB | S&P500 |
|---|---|---|
| 1-Week Return | -3.09% | 1.24% |
| 1-Month Return | -2.63% | 1.17% |
| 3-Month Return | 5.37% | 3.14% |
| 6-Month Return | 38.28% | 17.61% |
| 1-Year Return | 75.12% | 15.37% |
| 3-Year Return | 135.61% | 82.69% |
| 5-Year Return | 27.31% | 78.96% |
| 10-Year Return | 129.06% | 259.83% |
| Time Frame | BIB | S&P500 |
|---|---|---|
| 1-Week Return | -80.54% | 90.14% |
| 1-Month Return | -27.69% | 15.20% |
| 3-Month Return | 23.63% | 13.36% |
| 6-Month Return | 92.94% | 38.95% |
| 1-Year Return | 75.12% | 15.37% |
| 3-Year Return | 33.07% | 22.25% |
| 5-Year Return | 4.95% | 12.34% |
| 10-Year Return | 8.64% | 13.66% |
| Stock name | Ticker | Weight |
|---|---|---|
Net Other Assets (Liabilities)
|
Net.Other.Assets..Liabilities. |
25.52%
|
PROSHARES GENIUS MNY MKT ETF
|
IQMM |
18.46%
|
GILEAD SCIENCES INC
|
GILD |
4.54%
|
AMGEN INC
|
AMGN |
4.31%
|
VERTEX PHARMACEUTICALS INC
|
VRTX |
4.26%
|
MODERNA INC
|
MRNA |
2.85%
|
REGENERON PHARMACEUTICALS
|
REGN |
2.8%
|
REVOLUTION MEDICINES INC
|
RVMD |
1.67%
|
ILLUMINA INC
|
ILMN |
1.55%
|
BIOGEN INC
|
BIIB |
1.22%
|
ALNYLAM PHARMACEUTICALS INC
|
ALNY |
1.11%
|
ROIVANT SCIENCES LTD
|
ROIV |
0.97%
|
ROYALTY PHARMA PLC- CL A
|
RPRX |
0.96%
|
ARGENX SE - ADR
|
ARGX |
0.94%
|
INSMED INC
|
INSM |
0.91%
|
GUARDANT HEALTH INC
|
GH |
0.9%
|
INCYTE CORP
|
INCY |
0.88%
|
UNITED THERAPEUTICS CORP
|
UTHR |
0.87%
|
VIATRIS INC
|
VTRS |
0.76%
|
MEDPACE HOLDINGS INC
|
MEDP |
0.63%
|
JAZZ PHARMACEUTICALS PLC
|
JAZZ |
0.58%
|
NEUROCRINE BIOSCIENCES INC
|
NBIX |
0.55%
|
EXELIXIS INC
|
EXEL |
0.54%
|
ASCENDIS PHARMA A/S
|
ASND |
0.53%
|
BRIDGEBIO PHARMA INC
|
BBIO |
0.51%
|
TEMPUS AI INC-CL A
|
TEM |
0.51%
|
SUMMIT THERAPEUTICS INC
|
SMMT |
0.5%
|
BEONE MEDICINES LTD-ADR
|
ONC |
0.48%
|
TWIST BIOSCIENCE CORP
|
TWST |
0.47%
|
HALOZYME THERAPEUTICS INC
|
HALO |
0.47%
|
MADRIGAL PHARMACEUTICALS INC
|
MDGL |
0.43%
|
10X GENOMICS INC-CLASS A
|
TXG |
0.42%
|
BIONTECH SE-ADR
|
BNTX |
0.42%
|
BIOMARIN PHARMACEUTICAL INC
|
BMRN |
0.42%
|
IMMUNITYBIO INC
|
IBRX |
0.41%
|
KRYSTAL BIOTECH INC
|
KRYS |
0.36%
|
AXSOME THERAPEUTICS INC
|
AXSM |
0.35%
|
CYTOKINETICS INC
|
CYTK |
0.34%
|
ARROWHEAD PHARMACEUTICALS IN
|
ARWR |
0.34%
|
PROTAGONIST THERAPEUTICS INC
|
PTGX |
0.34%
|
KYMERA THERAPEUTICS INC
|
KYMR |
0.34%
|
SANOFI-ADR
|
SNY |
0.32%
|
VAXCYTE INC
|
PCVX |
0.32%
|
PRAXIS PRECISION MEDICINES I
|
PRAX |
0.31%
|
SPYRE THERAPEUTICS INC
|
SYRE |
0.31%
|
CARIS LIFE SCIENCES INC
|
CAI |
0.3%
|
IONIS PHARMACEUTICALS INC
|
IONS |
0.27%
|
AMNEAL PHARMACEUTICALS INC
|
AMRX |
0.27%
|
ALKERMES PLC
|
ALKS |
0.26%
|
IMMUNOVANT INC
|
IMVT |
0.26%
|
IOVANCE BIOTHERAPEUTICS INC
|
IOVA |
0.24%
|
GRAIL INC
|
GRAL |
0.24%
|
RHYTHM PHARMACEUTICALS INC
|
RYTM |
0.24%
|
LIGAND PHARMACEUTICALS
|
LGND |
0.23%
|
CG ONCOLOGY INC
|
CGON |
0.22%
|
KODIAK SCIENCES INC
|
KOD |
0.22%
|
SCHOLAR ROCK HOLDING CORP
|
SRRK |
0.21%
|
ORUKA THERAPEUTICS INC
|
ORKA |
0.21%
|
MIRUM PHARMACEUTICALS INC
|
MIRM |
0.2%
|
COGENT BIOSCIENCES INC
|
COGT |
0.2%
|
TRAVERE THERAPEUTICS INC
|
TVTX |
0.2%
|
CRISPR THERAPEUTICS AG
|
CRSP |
0.2%
|
ABIVAX SA-ADR
|
ABVX |
0.2%
|
PTC THERAPEUTICS INC
|
PTCT |
0.2%
|
ERASCA INC
|
ERAS |
0.19%
|
DEFINIUM THERAPEUTICS INC
|
DFTX |
0.19%
|
ADAPTIVE BIOTECHNOLOGIES
|
ADPT |
0.17%
|
EDGEWISE THERAPEUTICS INC
|
EWTX |
0.17%
|
ABCELLERA BIOLOGICS INC
|
ABCL |
0.17%
|
INDIVIOR PHARMACEUTICALS INC
|
INDV |
0.16%
|
RELAY THERAPEUTICS INC
|
RLAY |
0.16%
|
TANGO THERAPEUTICS INC
|
TNGX |
0.15%
|
VERACYTE INC
|
VCYT |
0.14%
|
XENON PHARMACEUTICALS INC
|
XENE |
0.14%
|
KINIKSA PHARMACEUTICALS INTE
|
KNSA |
0.14%
|
IDEAYA BIOSCIENCES INC
|
IDYA |
0.14%
|
AMYLYX PHARMACEUTICALS INC
|
AMLX |
0.13%
|
ENLIVEN THERAPEUTICS INC
|
ELVN |
0.13%
|
ACADIA PHARMACEUTICALS INC
|
ACAD |
0.13%
|
GENMAB A/S -SP ADR
|
GMAB |
0.13%
|
TARSUS PHARMACEUTICALS INC
|
TARS |
0.13%
|
DENALI THERAPEUTICS INC
|
DNLI |
0.12%
|
ARCUTIS BIOTHERAPEUTICS INC
|
ARQT |
0.12%
|
PRECIGEN INC
|
PGEN |
0.11%
|
DYNE THERAPEUTICS INC
|
DYN |
0.11%
|
MBX BIOSCIENCES INC
|
MBX |
0.11%
|
NEWAMSTERDAM PHARMA CO NV
|
NEWAMSTERDAM.PHARMA.CO.NV |
0.1%
|
BEAM THERAPEUTICS INC
|
BEAM |
0.1%
|
DISC MEDICINE INC
|
IRON |
0.09%
|
SUPERNUS PHARMACEUTICALS INC
|
SUPN |
0.09%
|
NURIX THERAPEUTICS INC
|
NRIX |
0.09%
|
HARMONY BIOSCIENCES HOLDINGS
|
HRMY |
0.09%
|
STRUCTURE THERAPEUTICS INC
|
GPCR |
0.09%
|
RECURSION PHARMACEUTICALS-A
|
RXRX |
0.08%
|
VERA THERAPEUTICS INC
|
VERA |
0.08%
|
PHARVARIS NV
|
PHVS |
0.08%
|
ADMA BIOLOGICS INC
|
ADMA |
0.08%
|
AURINIA PHARMACEUTICALS INC
|
AUPH |
0.08%
|
MINERALYS THERAPEUTICS INC
|
MLYS |
0.08%
|
BIOCRYST PHARMACEUTICALS INC
|
BCRX |
0.08%
|
VERICEL CORP
|
VCEL |
0.08%
|
UROGEN PHARMA LTD
|
URGN |
0.08%
|
TREVI THERAPEUTICS INC
|
TRVI |
0.07%
|
FORTREA HOLDINGS INC
|
FTRE |
0.07%
|
ABSCI CORP
|
ABSI |
0.07%
|
AGIOS PHARMACEUTICALS INC
|
AGIO |
0.07%
|
VIR BIOTECHNOLOGY INC
|
VIR |
0.07%
|
SAREPTA THERAPEUTICS INC
|
SRPT |
0.07%
|
XENCOR INC
|
XNCR |
0.07%
|
ZENAS BIOPHARMA INC
|
ZBIO |
0.07%
|
ALVOTECH SA
|
ALVO |
0.07%
|
ZYMEWORKS INC
|
ZYME |
0.07%
|
SEPTERNA INC
|
SEPN |
0.07%
|
NOVOCURE LTD
|
NVCR |
0.07%
|
PERSONALIS INC
|
PSNL |
0.07%
|
NOVAVAX INC
|
NVAX |
0.06%
|
INTELLIA THERAPEUTICS INC
|
NTLA |
0.06%
|
LEGEND BIOTECH CORP-ADR
|
LEGN |
0.06%
|
ANI PHARMACEUTICALS INC
|
ANIP |
0.06%
|
XERIS BIOPHARMA HOLDINGS INC
|
XERS |
0.06%
|
STOKE THERAPEUTICS INC
|
STOK |
0.06%
|
UNIQURE NV
|
QURE |
0.06%
|
COMPASS PATHWAYS PLC
|
CMPS |
0.06%
|
ETON PHARMACEUTICALS INC
|
ETON |
0.06%
|
GH RESEARCH PLC
|
GHRS |
0.06%
|
SYNDAX PHARMACEUTICALS INC
|
SNDX |
0.06%
|
RAPPORT THERAPEUTICS INC
|
RAPP |
0.06%
|
OCULAR THERAPEUTIX INC
|
OCUL |
0.06%
|
TAYSHA GENE THERAPIES INC
|
TSHA |
0.06%
|
ULTRAGENYX PHARMACEUTICAL IN
|
RARE |
0.06%
|
INNOVIVA INC
|
INVA |
0.06%
|
MAZE THERAPEUTICS INC
|
MAZE |
0.06%
|
ANAPTYSBIO INC
|
ANAB |
0.05%
|
INHIBRX BIOSCIENCES INC
|
INBX |
0.05%
|
ARRIVENT BIOPHARMA INC
|
AVBP |
0.05%
|
IMMUNOCORE HOLDINGS PLC-ADR
|
IMCR |
0.05%
|
OMEROS CORP
|
OMER |
0.05%
|
ORIC PHARMACEUTICALS INC
|
ORIC |
0.05%
|
REPLIMUNE GROUP INC
|
REPL |
0.05%
|
MANNKIND CORP
|
MNKD |
0.05%
|
TYRA BIOSCIENCES INC
|
TYRA |
0.05%
|
FIRST TRACKS BIOTHERAPEUTICS
|
TRAX |
0.04%
|
MARAVAI LIFESCIENCES HLDGS-A
|
MRVI |
0.04%
|
BICARA THERAPEUTICS INC
|
BCAX |
0.04%
|
HARROW INC
|
HROW |
0.04%
|
VOR BIOPHARMA INC
|
VOR |
0.04%
|
CASTLE BIOSCIENCES INC
|
CSTL |
0.04%
|
ZAI LAB LTD-ADR
|
ZLAB |
0.04%
|
AMPHASTAR PHARMACEUTICALS IN
|
AMPH |
0.04%
|
MEIRAGTX HOLDINGS PLC
|
MGTX |
0.04%
|
JANUX THERAPEUTICS INC
|
JANX |
0.04%
|
PACIRA BIOSCIENCES INC
|
PCRX |
0.04%
|
CULLINAN THERAPEUTICS INC
|
CGEM |
0.04%
|
SAVARA INC
|
SVRA |
0.04%
|
KURA ONCOLOGY INC
|
KURA |
0.04%
|
CORVUS PHARMACEUTICALS INC
|
CRVS |
0.03%
|
MONTE ROSA THERAPEUTICS INC
|
GLUE |
0.03%
|
GRIFOLS SA-ADR
|
GRFS |
0.03%
|
ALUMIS INC
|
ALMS |
0.03%
|
ARBUTUS BIOPHARMA CORP
|
ABUS |
0.03%
|
RIGEL PHARMACEUTICALS INC
|
RIGL |
0.03%
|
SANA BIOTECHNOLOGY INC
|
SANA |
0.03%
|
ARDELYX INC
|
ARDX |
0.03%
|
ANNEXON INC
|
ANNX |
0.03%
|
PACIFIC BIOSCIENCES OF CALIF
|
PACB |
0.03%
|
PHIBRO ANIMAL HEALTH CORP-A
|
PAHC |
0.03%
|
CANDEL THERAPEUTICS INC
|
CADL |
0.03%
|
DESIGN THERAPEUTICS INC
|
DSGN |
0.03%
|
GERON CORP
|
GERN |
0.03%
|
4D MOLECULAR THERAPEUTICS IN
|
FDMT |
0.03%
|
WAVE LIFE SCIENCES INC
|
WVE |
0.03%
|
MESOBLAST LTD- SPON ADR
|
MESO |
0.03%
|
SOLID BIOSCIENCES INC
|
SLDB |
0.03%
|
OLEMA PHARMACEUTICALS INC
|
OLMA |
0.03%
|
COLLEGIUM PHARMACEUTICAL INC
|
COLL |
0.03%
|
OMNIAB INC
|
OABI |
0.03%
|
ACLARIS THERAPEUTICS INC
|
ACRS |
0.02%
|
AURA BIOSCIENCES INC
|
AURA |
0.02%
|
IRONWOOD PHARMACEUTICALS INC
|
IRWD |
0.02%
|
ZEVRA THERAPEUTICS INC
|
ZVRA |
0.02%
|
AQUESTIVE THERAPEUTICS INC
|
AQST |
0.02%
|
SAGIMET BIOSCIENCES INC-A
|
SGMT |
0.02%
|
CORMEDIX INC
|
CRMD |
0.02%
|
PHATHOM PHARMACEUTICALS INC
|
PHAT |
0.02%
|
CYTOMX THERAPEUTICS INC
|
CTMX |
0.02%
|
PRIME MEDICINE INC
|
PRME |
0.02%
|
ALTIMMUNE INC
|
ALT |
0.02%
|
ALLOGENE THERAPEUTICS INC
|
ALLO |
0.02%
|
NEUROGENE INC
|
NGNE |
0.02%
|
SILENCE THERAPEUTICS PLC-ADR
|
SLN |
0.02%
|
PUMA BIOTECHNOLOGY INC
|
PBYI |
0.02%
|
REGENXBIO INC
|
RGNX |
0.02%
|
ARVINAS INC
|
ARVN |
0.02%
|
ALPHA TEKNOVA INC
|
TKNO |
0.02%
|
KAMADA LTD
|
KMDA |
0.02%
|
EVOLUS INC
|
EOLS |
0.02%
|
TECTONIC THERAPEUTIC INC
|
TECX |
0.02%
|
LAKEFRONT BIOTHERAPEUTIC-ADR
|
LKFT |
0.02%
|
CONTINEUM THERAPEUTICS INC-A
|
CTNM |
0.02%
|
PROTHENA CORP PLC
|
PRTA |
0.02%
|
ATEA PHARMACEUTICALS INC
|
AVIR |
0.02%
|
ARS PHARMACEUTICALS INC
|
SPRY |
0.02%
|
EDITAS MEDICINE INC
|
EDIT |
0.02%
|
KYVERNA THERAPEUTICS INC
|
KYTX |
0.01%
|
ENANTA PHARMACEUTICALS INC
|
ENTA |
0.01%
|
ARCTURUS THERAPEUTICS HOLDIN
|
ARCT |
0.01%
|
C4 THERAPEUTICS INC
|
CCCC |
0.01%
|
ORCHESTRA BIOMED HOLDINGS IN
|
OBIO |
0.01%
|
AUTOLUS THERAPEUTICS PLC
|
AUTL |
0.01%
|
CABALETTA BIO INC
|
CABA |
0.01%
|
QUANTUM-SI INC
|
QSI |
0.01%
|
LARIMAR THERAPEUTICS INC
|
LRMR |
0.01%
|
BIOAGE LABS INC
|
BIOA |
0.01%
|
LEXEO THERAPEUTICS INC
|
LXEO |
0.01%
|
FULCRUM THERAPEUTICS INC
|
FULC |
0.01%
|
ROCKET PHARMACEUTICALS INC
|
RCKT |
0.01%
|
EYEPOINT INC
|
EYPT |
0.01%
|
VANDA PHARMACEUTICALS INC
|
VNDA |
0.01%
|
AC IMMUNE SA
|
ACIU |
0.01%
|
UPSTREAM BIO INC
|
UPB |
0.01%
|
IMMUNEERING CORP - CLASS A
|
IMRX |
0.01%
|
LIFECORE BIOMEDICAL INC
|
LFCR |
0.01%
|
SIGA TECHNOLOGIES INC
|
SIGA |
0.01%
|
INVIVYD INC
|
IVVD |
0.01%
|
LYELL IMMUNOPHARMA INC
|
LYEL |
0.01%
|
KEROS THERAPEUTICS INC
|
KROS |
0.01%
|
SIONNA THERAPEUTICS INC
|
SION |
0.01%
|
ENTRADA THERAPEUTICS INC
|
TRDA |
0.01%
|
COHERUS ONCOLOGY INC
|
CHRS |
0.01%
|
PYXIS ONCOLOGY INC
|
PYXS |
0.01%
|
ANAVEX LIFE SCIENCES CORP
|
AVXL |
0.01%
|
JYONG BIOTECH LTD
|
MENS |
0.01%
|
BICYCLE THERAPEUTICS PLC-ADR
|
BCYC |
0.01%
|
PEPGEN INC
|
PEPG |
0.01%
|
NOVABRIDGE BIOSCIENCES
|
NBP |
0.01%
|
VOYAGER THERAPEUTICS INC
|
VYGR |
0.01%
|
CODEXIS INC
|
CDXS |
0.01%
|
HUMACYTE INC
|
HUMA |
0.01%
|
CARIBOU BIOSCIENCES INC
|
CRBU |
0%
|
TENAYA THERAPEUTICS INC
|
TNYA |
0%
|
FOGHORN THERAPEUTICS INC
|
FHTX |
0%
|
LENZ THERAPEUTICS INC
|
LENZ |
0%
|
AARDVARK THERAPEUTICS INC
|
AARD |
0%
|
BLACK DIAMOND THERAPEUTICS I
|
BDTX |
0%
|
NEUMORA THERAPEUTICS INC
|
NMRA |
0%
|
RANI THERAPEUTICS HOLDINGS-A
|
RANI |
0%
|
GOSSAMER BIO INC
|
GOSS |
0%
|
NASDAQ Biotechnology Index SWAP UBS AG
|
NASDAQ.Biotechnology.Index.SWAP.UBS.AG |
0%
|
NASDAQ Biotechnology Index SWAP Citibank NA
|
NASDAQ.Biotechnology.Index.SWAP.Citibank.NA |
0%
|
CARTESIAN THERAPEUTICS-CVR
|
CARTESIAN.THERAPEUTICS.CVR |
0%
|
NASDAQ Biotechnology Index SWAP Societe Generale
|
NASDAQ.Biotechnology.Index.SWAP.Societe.Generale |
0%
|
CONTRA CVR COHERUS ONC
|
CONTRA.CVR.COHERUS.ONC |
0%
|
THIRD HARMONIC BIO INC
|
THRD |
0%
|
NASDAQ Biotechnology Index SWAP Bank of America NA
|
NASDAQ.Biotechnology.Index.SWAP.Bank.of.America.NA |
0%
|
NASDAQ Bio Index SWAP BNP Paribas
|
NASDAQ.Bio.Index.SWAP.BNP.Paribas |
0%
|
NASDAQ Biotechnology Index SWAP Goldman Sachs International
|
NASDAQ.Biotechnology.Index.SWAP.Goldman.Sachs.International |
0%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
ProShares Ultra Nasdaq Biotechnology (BIB) share price today is $106.883.
Yes, Indians can buy shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. To buy BIB from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. You can start investing in ProShares Ultra Nasdaq Biotechnology (BIB) with a minimum investment of $1.
The 52-week high price of ProShares Ultra Nasdaq Biotechnology (BIB) is $126.31. The 52-week low price of ProShares Ultra Nasdaq Biotechnology (BIB) is $62.57.
The stock symbol (or ticker) of ProShares Ultra Nasdaq Biotechnology is BIB.
Yes, you can setup SIP in ProShares Ultra Nasdaq Biotechnology shares. Follow the below steps to create the SIP:
Here is the historical performance of BIB on the Vested app.
The expense ratio of ProShares Ultra Nasdaq Biotechnology (BIB) is 0.95%.
Link copied